MX26167A - Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino. - Google Patents
Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.Info
- Publication number
- MX26167A MX26167A MX2616791A MX2616791A MX26167A MX 26167 A MX26167 A MX 26167A MX 2616791 A MX2616791 A MX 2616791A MX 2616791 A MX2616791 A MX 2616791A MX 26167 A MX26167 A MX 26167A
- Authority
- MX
- Mexico
- Prior art keywords
- lecotrine
- piridil
- derivatives
- treatment
- benzoic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53439790A | 1990-06-07 | 1990-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX26167A true MX26167A (es) | 1994-02-28 |
Family
ID=24129867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2616791A MX26167A (es) | 1990-06-07 | 1991-06-07 | Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0593464A1 (es) |
| JP (1) | JPH07116150B2 (es) |
| KR (1) | KR930700102A (es) |
| CN (1) | CN1058015A (es) |
| AU (1) | AU655428B2 (es) |
| CA (1) | CA2083957A1 (es) |
| FI (1) | FI925545A0 (es) |
| HU (1) | HUT64747A (es) |
| IL (1) | IL98387A0 (es) |
| MA (1) | MA22195A1 (es) |
| MX (1) | MX26167A (es) |
| NZ (1) | NZ238426A (es) |
| PL (1) | PL290587A1 (es) |
| PT (1) | PT97913A (es) |
| TW (1) | TW221809B (es) |
| WO (1) | WO1991018601A1 (es) |
| ZA (1) | ZA914322B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2573592A (en) * | 1991-09-19 | 1993-04-27 | Smithkline Beecham Corporation | Pyridine compounds for treating leukotriene-related diseases |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| JP3181917B2 (ja) * | 1992-06-30 | 2001-07-03 | スミスクライン・ビーチャム・コーポレイション | フェニルチオメチルピリジニルアルケノアート類の製造方法 |
| DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
| GR1001409B (el) * | 1992-10-15 | 1993-11-30 | Smithkline Beecham Corp | Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια. |
| ES2065234B1 (es) * | 1992-10-27 | 1995-09-01 | Smithkline Beecham Corp | Compuestos para tratar enfermedades relacionadas con los leucotrienos. |
| US5643914A (en) * | 1993-03-02 | 1997-07-01 | Smithkline Beecham Corporation | Pharmaceutical pyridine compounds |
| US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
| AU4557397A (en) * | 1996-09-26 | 1998-04-17 | Novartis Ag | Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| US7850970B2 (en) | 2003-08-26 | 2010-12-14 | The Regents Of The University Of Colorado | Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
| EP3812363B1 (en) * | 2018-06-22 | 2022-08-03 | Panasonic Holdings Corporation | Organic salt, hydroxy-radical sensor including same, and detection medium |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056619A (en) * | 1975-09-08 | 1977-11-01 | Warner-Lambert Company | 1-Substituted-2-(2-pyridinyl)ethanone N-oxides |
-
1991
- 1991-05-31 HU HU9203867A patent/HUT64747A/hu unknown
- 1991-05-31 CA CA002083957A patent/CA2083957A1/en not_active Abandoned
- 1991-05-31 KR KR1019920703091A patent/KR930700102A/ko active IP Right Grant
- 1991-05-31 WO PCT/US1991/003772 patent/WO1991018601A1/en not_active Application Discontinuation
- 1991-05-31 AU AU81896/91A patent/AU655428B2/en not_active Ceased
- 1991-05-31 EP EP91911699A patent/EP0593464A1/en not_active Ceased
- 1991-05-31 JP JP3511468A patent/JPH07116150B2/ja not_active Expired - Lifetime
- 1991-06-03 MA MA22441A patent/MA22195A1/fr unknown
- 1991-06-05 IL IL98387A patent/IL98387A0/xx unknown
- 1991-06-06 NZ NZ238426A patent/NZ238426A/en unknown
- 1991-06-06 ZA ZA914322A patent/ZA914322B/xx unknown
- 1991-06-06 TW TW080104434A patent/TW221809B/zh active
- 1991-06-07 PT PT97913A patent/PT97913A/pt not_active Application Discontinuation
- 1991-06-07 CN CN91104563A patent/CN1058015A/zh active Pending
- 1991-06-07 PL PL29058791A patent/PL290587A1/xx unknown
- 1991-06-07 MX MX2616791A patent/MX26167A/es unknown
-
1992
- 1992-12-07 FI FI925545A patent/FI925545A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8189691A (en) | 1991-12-31 |
| MA22195A1 (fr) | 1992-04-01 |
| FI925545A (fi) | 1992-12-07 |
| ZA914322B (en) | 1992-06-24 |
| JPH07116150B2 (ja) | 1995-12-13 |
| FI925545A0 (fi) | 1992-12-07 |
| NZ238426A (en) | 1994-11-25 |
| WO1991018601A1 (en) | 1991-12-12 |
| EP0593464A4 (en) | 1993-02-12 |
| CN1058015A (zh) | 1992-01-22 |
| PL290587A1 (en) | 1992-08-24 |
| IL98387A0 (en) | 1992-07-15 |
| PT97913A (pt) | 1992-03-31 |
| EP0593464A1 (en) | 1994-04-27 |
| HU9203867D0 (en) | 1993-03-29 |
| TW221809B (es) | 1994-03-21 |
| KR930700102A (ko) | 1993-03-13 |
| HUT64747A (en) | 1994-02-28 |
| JPH05507492A (ja) | 1993-10-28 |
| AU655428B2 (en) | 1994-12-22 |
| CA2083957A1 (en) | 1991-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20115753A (fi) | Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon | |
| DE3873855D1 (de) | Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten. | |
| MX9200216A (es) | Procedimiento para la preparacion de anhidrido de acido malonico. | |
| FI953899A (fi) | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi | |
| FI98067B (fi) | Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi | |
| MX26167A (es) | Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino. | |
| MX9205434A (es) | Derivados del acido imidazolil-propenico substituidos ciclicamente y procedimiento para su fabricacion. | |
| IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
| AR228396A1 (es) | Metodo para la preparacion de composiciones farmaceuticas para el tratamiento de la piel | |
| MX26142A (es) | Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno. | |
| IT8621892A0 (it) | Procedimento per la sintesi di acido tauroursodesossicolico biidrato. | |
| FI911701A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi | |
| IT1122111B (it) | Procedimento per la purificazione di resorcina grezza | |
| PT88432A (pt) | Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents | |
| IT1229522B (it) | Procedimento per la preparazione di acido n fosfonometiliminodiacetico. | |
| MX9204847A (es) | Procedimiento para la produccion de acetato de metilo. | |
| ES509802A0 (es) | Procedimiento para preparar antibioticos y antitumorigenos de la familia de bleomicina-fleomicina, designados ll-b01208 y ll-b01208 y las sales de adicion de acido farmaceuticamente aceptables de los mismos. | |
| NO912636D0 (no) | Fremgangsmaate for fremstilling av svovelsubstituerte mevininsyre-derivater. | |
| FI930532A0 (fi) | Foerfarande foer separering av organiska bestaondsdelar ur gasblandningar | |
| NO158416C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme pentandisyrederivater. | |
| IT7919854A0 (it) | Procedimento per la purificazione di acido tereftalico. | |
| MX9204485A (es) | Composicion farmaceutica para el tratamiento de enfermedades inflamatorias. | |
| NO924701D0 (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer | |
| NO924702L (no) | Pyridyl-benzosyrederivater for behandling av leukotrien-relaterte sykdommer | |
| IT9021967A0 (it) | Composizioni farmaceutiche contenenti acido 2-(2-pirrolidon-5-carbonilamido)-3-mercaptopropionico, per il trattamento di malattie connesse auna carenza di glutatione |